Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer

Prof Lorenzo Livi - Careggi Hospital, Florence, Italy
New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer ( Prof Lorenzo Livi - Careggi Hospital, Florence, Italy )
16 Dec 2014

Tamoxifen lowered breast cancer rates among high-risk women

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Tamoxifen lowered breast cancer rates among high-risk women ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
16 Dec 2014

Fulvestrant versus anastrozole in patients with advanced breast cancer

Prof John Robertson - Royal Derby Hospital, Derby, UK
Fulvestrant versus anastrozole in patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )
16 Dec 2014

Reducing fat intake reduces death rates in some breast cancer patients

Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA
Reducing fat intake reduces death rates in some breast cancer patients ( Professor Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )
16 Dec 2014

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )
16 Dec 2014

Breast cancer in men and women has different biological characteristics and outcomes

Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal
Breast cancer in men and women has different biological characteristics and outcomes ( Dr Fatima Cardoso - Champalimaud Cancer Center, Lisbon, Portugal )
15 Dec 2014

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Dr Rita Nanda - University of Chicago Medicine, Chicago, USA
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer ( Dr Rita Nanda - University of Chicago Medicine, Chicago, USA )
12 Dec 2014

Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA
Comment: Impact of combined bevacizumab and presurgery chemo varies by subtype ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )
12 Dec 2014

Adding ultrasound to routine mammography improves cancer detection in dense breasts

Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA
Adding ultrasound to routine mammography improves cancer detection in dense breasts ( Dr Jean Weigert - Cancer Center of Central Connecticut, New Britain, USA )
12 Dec 2014

High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo

Dr Edith Perez - Mayo Clinic, Rochester, USA
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo ( Dr Edith Perez - Mayo Clinic, Rochester, USA )
12 Dec 2014

CLL at ASH 2014: Expert discussion

Prof John Gribben and Prof Stephan Stilgenbauer
CLL at ASH 2014: Expert discussion ( Prof John Gribben and Prof Stephan Stilgenbauer )
12 Dec 2014

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA
BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )
12 Dec 2014